UL Launches Medical IoT Battery SOH Transparency Certification Pilot

On May 12, 2026, UL Solutions initiated a pilot program for its Medical IoT Battery State-of-Health (SOH) Transparency Certification—targeting wearable micro-sensors and fitness tracking sensors. This development directly impacts manufacturers and exporters supplying to U.S., Canadian, and Mexican healthcare procurement programs, and signals consequential shifts for Chinese sensor module suppliers aiming for medical-grade market access and regulatory compliance.

Event Overview

UL Solutions launched the Medical IoT Battery SOH Transparency Certification pilot on May 12, 2026. The pilot mandates that wearable micro-sensors and fitness tracking sensors must report battery State-of-Health (SOH) parameters—including remaining capacity, cycle count, and internal resistance changes—in real time. These devices must be validated per Annex G of UL 2849:2026. The pilot initially applies to products listed in the healthcare procurement catalogs of the United States, Canada, and Mexico.

Industries Affected

Direct Exporters (U.S./Canada/Mexico-Focused)

Exporters whose micro-sensor or fitness tracking sensor modules are currently supplied—or planned for supply—to public healthcare procurement channels in the U.S., Canada, or Mexico will face new technical eligibility requirements. Impact manifests as revised pre-market validation timelines, potential delays in catalog listing, and increased documentation burden tied to real-time SOH data architecture and UL 2849:2026 Annex G conformance.

Sensor Module Manufacturers (China-Based)

Chinese OEMs and ODMs producing medical-adjacent or dual-use sensor modules for global wearable OEMs may encounter upstream compliance requests from customers preparing for UL’s pilot. Impact includes accelerated demand for SOH-aware firmware design, battery telemetry integration, and traceable calibration records—especially where modules are branded or co-branded under healthcare procurement contracts.

Medical Device Contract Manufacturers (CMs)

Contract manufacturers assembling finished wearable devices intended for regulated health procurement markets must now assess whether their current battery management systems (BMS) and firmware support real-time SOH parameter extraction and reporting. Impact centers on verification readiness—not only for UL 2849:2026 Annex G but also for interoperability with healthcare IT infrastructure expecting standardized SOH data feeds.

Supply Chain Compliance & Certification Service Providers

Firms offering testing, certification support, or regulatory gap analysis for IoT hardware must update service scopes to include SOH telemetry architecture review, firmware logging validation, and UL 2849:2026 Annex G test planning. Impact lies in shifting client engagement earlier in product development cycles—and requiring cross-functional coordination between battery engineers, firmware developers, and certification specialists.

What Relevant Enterprises or Practitioners Should Focus On — And How to Respond Now

Monitor official updates from UL Solutions regarding pilot scope expansion and timeline formalization

The pilot is currently limited to specific procurement-listed products in three countries. UL has not yet published a public roadmap for full program rollout, transition deadlines, or inclusion criteria beyond the initial scope. Stakeholders should subscribe to UL’s official regulatory alerts and track announcements referencing UL 2849:2026 Annex G implementation guidance.

Identify and prioritize SKUs already aligned—or misaligned—with real-time SOH telemetry requirements

Manufacturers should conduct an internal audit of existing micro-sensor and fitness tracking sensor product lines: which models log and expose battery capacity, cycle count, and internal resistance via accessible interfaces (e.g., I²C registers, BLE GATT characteristics, or diagnostic APIs). Prioritization should focus first on SKUs referenced in U.S./CA/MX healthcare procurement tenders or under active bid evaluation.

Distinguish between policy signal and enforceable requirement at this stage

This remains a voluntary pilot—not a mandatory standard or regulatory mandate. Participation is not required for general market entry, but it is becoming a de facto gatekeeper for public-sector procurement eligibility in North America. Enterprises should avoid conflating pilot participation with broad regulatory adoption; however, they should treat it as an early indicator of convergence toward SOH transparency as a baseline expectation for medical IoT hardware.

Initiate cross-functional alignment on firmware, battery sourcing, and test documentation practices

Engineering teams should begin scoping minimal viable changes to enable SOH parameter exposure: e.g., validating existing fuel gauge ICs for cycle count accuracy, confirming internal resistance measurement methodology meets Annex G repeatability thresholds, and documenting data logging intervals and error-handling logic. Procurement teams should verify whether current battery cell or pack suppliers provide SOH-relevant characterization reports traceable to UL 2849:2026 Annex G test conditions.

Editorial Perspective / Industry Observation

Observably, this pilot functions primarily as a signaling mechanism—not an immediate compliance deadline. It reflects UL’s strategic alignment with evolving FDA and Health Canada expectations around device longevity, predictive maintenance, and cyber-physical safety in connected health hardware. Analysis shows that while no enforcement action accompanies the pilot launch, its linkage to national procurement catalogs elevates its practical weight far beyond typical voluntary certifications. From an industry perspective, this is less about imminent regulatory penalty and more about anticipatory infrastructure investment: enterprises building SOH-aware telemetry now gain lead time in qualifying for future tenders and reducing late-stage redesign risk. Current observability suggests the pilot is being used to stress-test both technical feasibility and ecosystem readiness—including cloud platform ingestion of SOH streams and clinician-facing dashboard rendering.

Conclusion: This initiative marks a procedural inflection point—not a regulatory milestone—where SOH transparency transitions from a design option to a procurement prerequisite in select North American healthcare contexts. It is best understood not as a finalized standard, but as a field test shaping how battery health accountability will be operationalized across medical IoT value chains. Enterprises should treat it as a high-fidelity rehearsal for upcoming technical expectations, not as a static compliance target.

Source: UL Solutions official announcement (May 12, 2026); UL 2849:2026 Standard, Annex G (publicly available edition).
Noted for ongoing observation: UL’s timeline for pilot evaluation summary publication, potential expansion to EU or APAC procurement frameworks, and any revision to Annex G’s technical thresholds following pilot feedback.